Requests similar to 'Equity of access for low side-effect formulations for therapeutic treatment of anxiety, depression & ADHD'
Hardys Daily Nutrients reclassified from dietary supplement to prescription medicine
Request sent to Ministry of Health by J Bruning on .
Partially successful.
OIA request, October 1, 2024.
Regarding: Hardy Nutritionals Daily Essential Nutrients (DEN).
A September 22, 2024 release by Hardy Nutritionals st...
2 - ADHD Services, Pathways, Data, and Outcomes (National)
Response by Health New Zealand to Elspeth Baker-Vevers on .
Partially successful.
Kia ora Elspeth,
Thank you for your request for information regarding ADHD Services,
Pathways, Data, and Outcomes (National) on 28/11/2025. Pleas...
Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments
Response by Pharmaceutical Management Agency to J Bruning on .
Successful.
Kia ora
Please find a response to your request for information attached with this email.
Ngā mihi
Melody Willis (she/her) | Government Services Adv...
7 - ADHD Medicines, Funding, Access, and Equity
Response by Pharmaceutical Management Agency to Elspeth Baker-Vevers on .
Awaiting classification.
Kia ora Elspeth,
Please find attached our response letter and the relevant documents
released to you under the Official Information Act.
...
35 - Ownership, governance, and operational rollout of the ADHD Clinical Principles Framework (February 2026)
Response by Ministry of Health to Elspeth Baker-Vevers on .
Awaiting classification.
Kia ora Elspeth
Please find attached part 3 of 5 of the response to your request for
official information.
Ngā mihi,
OIA Ser...
6 - ADHD Cross-Agency Governance or Strategy
Response by Department of the Prime Minister and Cabinet to Elspeth Baker-Vevers on .
Awaiting classification.
Kia ora Elspeth
Please find attached the response to your request for official
information.
Ngā mihi,
OIA Services Team
Minis...
Under 40s - extent of co-prescribing for ADHD, anxiety, depression.
Response by Pharmaceutical Management Agency to J Bruning on .
Partially successful.
Kia ora Jodie,
Please find attached a response to your Official Information Act request,
which was received on 2 October 2024.
Please cont...
Discontinuation of Phenelzine Sulphare
Response by Pharmaceutical Management Agency to Megs on .
Successful.
Dear Megs
Attached is PHARMAC's response to your recent information request.
Kind regards
PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9,...
Stimulant medicine ADHD lisdexamfetamine - clear health benefit - efficacy and safety data
Response by Pharmaceutical Management Agency to J Bruning on .
Awaiting classification.
Kia ora J
Please find attached a response to your request for official information.
Ngâ mihi,
Government Services | Pharmac
________________________...
The 2022 Therapeutic Products Bill
Response by Andrew Little to Tracy Livingston on .
Awaiting classification.
Kia ora Tracy,
Please find attached a response to your request for information.
Ngā mihi
OIA Services Team
Manatū Hauora | Ministry of Hea...
Minutes from the 113th meeting of the Medicines Assessment Advisory Committee (MAAC)
Response by Ministry of Health to Maxwell on .
Successful.
Kia ora Maxwell
Please find attached a letter regarding your request for information
Ngā mihi
OIA Services Team
[1]Ministry of Health in...
Kia ora A Mark
Please find attached a response to your request for information regarding
funding decisions for Trikafta.
Ngā mihi
...
Budget 2025: Extent of funding for nutrition-related policy & work programmes
Request sent to Shane Reti by J Bruning on .
Successful.
Increasingly, conventional medical clinicians and general practitioners operate with one arm behind their back, on the surface, oblivious in the fac...
Classification of Artemisia Annua L.
Response by Ministry of Health to Morgan Varaine on .
Awaiting classification.
Kia ora Morgan,
Please find attached a response regarding your request for information.
Ngā mihi
OIA Services Team
[1]Mi...
Vanlafaxine - Bioavailability studies
Response by Pharmaceutical Management Agency to R Whyte on .
Awaiting classification.
Dear R Whyte
Please see attached the response to your OIA request.
Kind regards
Dean Zeng
PHARMAC
16 April 2018
Via Email: [e...
Assessment bias toward new medicines - Ivermectin and Pfizer antiviral PF-07321332
Response by Ministry of Health to Adam Irish on .
Partially successful.
Kia ora Adam
Please find a response to your request attached with this email.
Ngā mihi
Melody Willis ([1]she/her) | Government Se...
Altered composition of Comirnaty BNT162b2
Response by Ministry of Health to Catherine Jamieson on .
Partially successful.
Kia ora Catherine,
Thank you for your email. Below is some further information relating to
Comirnaty (Pfizer/BioNTech) vaccine.
Informatio...
Testing and Therapeutics Technical Advisory Groups documents
Response by Ministry of Health to Harold on .
Successful.
Kia ora Harold
Please find attached the response to your request for official
information.
Ngā mihi
OIA Services Team
[1]Ministry of H...
1 - ADHD Policy, Governance, Data, and Rights Oversight
Response by Ministry of Health to Elspeth Baker-Vevers on .
Delayed.
Kia ora Elspeth
Please find attached the response to your request for official
information.
Ngā mihi,
OIA Services Team
Minis...
Removal of Approved Drugs / Medicine
Response by Ministry of Health to Chris McCashin on .
Awaiting classification.
Kia ora Chris,
Please find attached the response for your request for official
information.
Ngā mihi
OIA Services Team
Manatū Hauora | Ministr...
Kia ora El Zorro,
Please find attached a letter regarding your request for information.
Ngā mihi
OIA Services
Government Services...
Medicinal Cannabis
Response by Accident Compensation Corporation to Anthony Jordan on .
Awaiting classification.
Kia ora Anthony,
Please find attached our response to your official information request
dated 21 May 2023. If you have any questions about the resp...
16 - ADHD Recognition, Data, and Support
Response by Department of Corrections to Elspeth Baker-Vevers on .
Successful.
Kia ora Elspeth,
Please see the attached OIA response from Corrections.
Ngâ mihi | Kind regards,
Government Services – Official Corre...
Information pertaining to item 8.2.1 in the Minutes of the 63rd meeting of the Medicines Classification Committee held in Wellington on 10 October 2019 at 9:39 am
Response by Medicines Classification Committee to S Mills on .
Partially successful.
Kia ora S Mills
Please find attached a response to your request for official information
along with the relevant supporting documents.
Nga mihi...
Kia ora Wendy,
Thank you for your email.
For Ivermectin to be approved for the prevention or treatment of COVID-19
New Zealand legislatio...